Commonwealth Equity Services’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-45,582
Closed -$186K 3855
2022
Q1
$186K Sell
45,582
-1,100
-2% -$4.49K ﹤0.01% 3361
2021
Q4
$166K Sell
46,682
-5,516
-11% -$19.6K ﹤0.01% 3354
2021
Q3
$190K Sell
52,198
-1,406
-3% -$5.12K ﹤0.01% 3293
2021
Q2
$233K Sell
53,604
-2,600
-5% -$11.3K ﹤0.01% 3137
2021
Q1
$231K Sell
56,204
-7,465
-12% -$30.7K ﹤0.01% 3008
2020
Q4
$254K Buy
63,669
+776
+1% +$3.1K ﹤0.01% 2717
2020
Q3
$169K Buy
62,893
+400
+0.6% +$1.08K ﹤0.01% 2779
2020
Q2
$171K Buy
62,493
+10,300
+20% +$28.2K ﹤0.01% 2664
2020
Q1
$123K Buy
52,193
+1,000
+2% +$2.36K ﹤0.01% 2538
2019
Q4
$240K Sell
51,193
-10,400
-17% -$48.8K ﹤0.01% 2487
2019
Q3
$206K Buy
61,593
+1,650
+3% +$5.52K ﹤0.01% 2529
2019
Q2
$197K Buy
59,943
+3,800
+7% +$12.5K ﹤0.01% 2512
2019
Q1
$170K Sell
56,143
-3,500
-6% -$10.6K ﹤0.01% 2504
2018
Q4
$162K Sell
59,643
-500
-0.8% -$1.36K ﹤0.01% 2389
2018
Q3
$202K Buy
60,143
+270
+0.5% +$907 ﹤0.01% 2502
2018
Q2
$154K Sell
59,873
-1,500
-2% -$3.86K ﹤0.01% 2532
2018
Q1
$135K Buy
61,373
+2,000
+3% +$4.4K ﹤0.01% 2498
2017
Q4
$118K Buy
59,373
+5,700
+11% +$11.3K ﹤0.01% 2492
2017
Q3
$174K Buy
53,673
+4,350
+9% +$14.1K ﹤0.01% 2327
2017
Q2
$159K Buy
49,323
+4,987
+11% +$16.1K ﹤0.01% 2302
2017
Q1
$126K Sell
44,336
-1,294
-3% -$3.68K ﹤0.01% 2261
2016
Q4
$106K Buy
45,630
+1,700
+4% +$3.95K ﹤0.01% 2187
2016
Q3
$74K Buy
43,930
+530
+1% +$893 ﹤0.01% 2148
2016
Q2
$46K Hold
43,400
﹤0.01% 2163
2016
Q1
$38K Hold
43,400
﹤0.01% 2145
2015
Q4
$53K Buy
43,400
+3,000
+7% +$3.66K ﹤0.01% 2097
2015
Q3
$69K Sell
40,400
-7,000
-15% -$12K ﹤0.01% 2022
2015
Q2
$99K Sell
47,400
-4,500
-9% -$9.4K ﹤0.01% 2071
2015
Q1
$141K Sell
51,900
-56,000
-52% -$152K ﹤0.01% 2005
2014
Q4
$277K Buy
107,900
+17,750
+20% +$45.6K ﹤0.01% 1616
2014
Q3
$165K Buy
90,150
+10,750
+14% +$19.7K ﹤0.01% 1879
2014
Q2
$212K Sell
79,400
-4,300
-5% -$11.5K ﹤0.01% 1788
2014
Q1
$293K Sell
83,700
-6,250
-7% -$21.9K ﹤0.01% 1494
2013
Q4
$402K Buy
89,950
+12,400
+16% +$55.4K 0.01% 1265
2013
Q3
$315K Buy
77,550
+35,300
+84% +$143K 0.01% 1337
2013
Q2
$176K Buy
+42,250
New +$176K ﹤0.01% 1596